ROS and Antioxidants: Prospective Therapeutic Options in Cancer
Journal of Cellular and Molecular Medicine · 2026-07 · 30 (14)
DOI: 10.1111/jcmm.71288 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 14.07.2026. Verfasst von Kostas A Papavassiliou und 3 weiteren Autor:innen. Beteiligte Einrichtung: First University Department of Respiratory Medicine, 'Sotiria' Chest Hospital, Medical School, National and Kapodistrian University of Athens, Athens…. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First University Department of Respiratory Medicine, 'Sotiria' Chest Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
- Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
ORCID-Profile: Kostas A Papavassiliou, Athanasios G Papavassiliou
Zitieren
APA
Papavassiliou, K. A., Sofianidi, A. A., Margoni, A., & Papavassiliou, A. G. (2026). ROS and Antioxidants: Prospective Therapeutic Options in Cancer. Journal of Cellular and Molecular Medicine, 30(14). https://doi.org/10.1111/jcmm.71288
Vancouver
Papavassiliou KA, Sofianidi AA, Margoni A, Papavassiliou AG. ROS and Antioxidants: Prospective Therapeutic Options in Cancer. Journal of Cellular and Molecular Medicine. 2026;30(14). doi:10.1111/jcmm.71288
BibTeX
@article{Papavassiliou2026,
author = {Papavassiliou, Kostas A and Sofianidi, Amalia A and Margoni, Angeliki and Papavassiliou, Athanasios G},
title = {ROS and Antioxidants: Prospective Therapeutic Options in Cancer},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
volume = {30},
number = {14},
doi = {10.1111/jcmm.71288}
}
EUVIMED